AU1350099A - Formulations for topical treatment of skin infections - Google Patents

Formulations for topical treatment of skin infections

Info

Publication number
AU1350099A
AU1350099A AU13500/99A AU1350099A AU1350099A AU 1350099 A AU1350099 A AU 1350099A AU 13500/99 A AU13500/99 A AU 13500/99A AU 1350099 A AU1350099 A AU 1350099A AU 1350099 A AU1350099 A AU 1350099A
Authority
AU
Australia
Prior art keywords
formulations
topical treatment
skin infections
infections
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13500/99A
Inventor
Yechezkel Barenholz
Shoshana Frankenburg
Dvora Glick
Sidney N. Klaus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yissum Research Development Co of Hebrew University of Jerusalem
Original Assignee
Yissum Research Development Co of Hebrew University of Jerusalem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Research Development Co of Hebrew University of Jerusalem filed Critical Yissum Research Development Co of Hebrew University of Jerusalem
Publication of AU1350099A publication Critical patent/AU1350099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU13500/99A 1997-12-01 1998-11-30 Formulations for topical treatment of skin infections Abandoned AU1350099A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6748597P 1997-12-01 1997-12-01
US60067485 1997-12-01
US10178398P 1998-09-25 1998-09-25
US60101783 1998-09-25
PCT/IL1998/000582 WO1999027940A1 (en) 1997-12-01 1998-11-30 Formulations for topical treatment of skin infections

Publications (1)

Publication Number Publication Date
AU1350099A true AU1350099A (en) 1999-06-16

Family

ID=26747915

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13500/99A Abandoned AU1350099A (en) 1997-12-01 1998-11-30 Formulations for topical treatment of skin infections

Country Status (3)

Country Link
AU (1) AU1350099A (en)
IL (1) IL136342A0 (en)
WO (1) WO1999027940A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307079D0 (en) * 2003-03-27 2003-04-30 Stone Island Holdings Ltd Allicin
CN1812766A (en) 2003-04-25 2006-08-02 宾州研究基金会 Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
ES2387440B2 (en) * 2010-09-27 2014-02-04 Universidad Complutense De Madrid TOPIC FORMULATIONS OF ANPHOTERICINE B AND METHOD OF OBTAINING

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT78628B (en) * 1984-05-02 1986-06-18 Liposome Co Inc Pharmaceutical composition with reduced toxicity
FR2593394A1 (en) * 1986-01-30 1987-07-31 Ire Celltarg Sa Method for preparing liposomes containing a lipophilic active substance, in particular amphotericin, and liposomes and new medicament which are obtained
IE60901B1 (en) * 1986-08-21 1994-08-24 Vestar Inc Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics
WO1990006775A1 (en) * 1988-12-14 1990-06-28 Liposome Technology, Inc. A novel nonphospholipid liposome composition for sustained release of drugs
US5277914A (en) * 1989-03-31 1994-01-11 The Regents Of The University Of California Preparation of liposome and lipid complex compositions
FR2651680B1 (en) * 1989-09-14 1991-12-27 Medgenix Group Sa NOVEL PROCESS FOR THE PREPARATION OF LIPID MICROPARTICLES.
JP2785981B2 (en) * 1989-11-20 1998-08-13 株式会社資生堂 Emulsion composition
DE4208527A1 (en) * 1992-03-17 1993-09-23 Max Planck Gesellschaft LIPOSOMES WITH NEGATIVE EXCESS CHARGE

Also Published As

Publication number Publication date
WO1999027940A1 (en) 1999-06-10
IL136342A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
AU3406997A (en) Topical product formulations containing strontium for reducing skin irritation
EP0815838A3 (en) External skin treatment composition
AU4861196A (en) Formulations and methods for reducing skin irritation
AU6273796A (en) Nucleotide analogues for topical treatment of proliferative disease of the skin
AU7496498A (en) Skin care compositions
AU2911100A (en) Skin cosmetic composition
AU4868396A (en) Skin care composition
AUPQ877300A0 (en) Topical treatment of skin
AU1773600A (en) Topical treatment of skin disease
AU7462396A (en) Skin care compositions
AU1784301A (en) Topical skin composition
AU4774597A (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
AU1592099A (en) Skin care composition
AU8038998A (en) Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters
AU2036297A (en) Topical formulations of aciclovir
AU6114998A (en) Topical nifedipine preparations for the conservative treatment of functional pathologies of the anal canal
AU1876797A (en) Topical formulations for the treatment of nail psoriasis
AU7106300A (en) Treatment of skin disorders
AU2068295A (en) Skin treatment composition
AU1249395A (en) Topical treatment of ocular photophobia
AU1350099A (en) Formulations for topical treatment of skin infections
AU5341299A (en) Cosmetic composition for rejuvenation of skin without skin irritation
AU5699396A (en) Compositions for the treatment of skin conditions
AU2002212489A1 (en) Veterinary composition for the topical treatment of traumatized or inflamed skin
AU4145999A (en) Topical drug for the treatment of viral infections

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase